Area of research
Cancer Research · Immunology
Research interest
Research interests include NF-κB Signaling Pathways, Lymphoma Diagnosis and Treatment, CNS Lymphoma Diagnosis and Treatment, and Immune Response and Inflammation.
Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival
BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis
Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stress
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
The Paracaspase MALT1 in Cancer
Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL
Impaired Autophagy in Psoriasis and Atopic Dermatitis: A New Therapeutic Target?
The paracaspase MALT1 in psoriasis
Classification and Nomenclature of Metacaspases and Paracaspases: No More Confusion with Caspases
The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis
Threonine Phosphorylation of IκBζ Mediates Inhibition of Selective Proinflammatory Target Genes
Keratinocyte-derived IκBζ drives psoriasis and associated systemic inflammation
Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma
Temporal Dynamics of Reactive Oxygen and Nitrogen Species and NF-κB Activation During Acute and Chronic T Cell–Driven Inflammation
IκBζ is a key transcriptional regulator of IL-36–driven psoriasis-related gene expression in keratinocytes
The Atypical Inhibitor of NF-κB, IκBζ, Controls Macrophage Interleukin-10 Expression
IκBζ is a key driver in the development of psoriasis
The paracaspase <scp>MALT</scp>1 dampens <scp>NF</scp>‐κB signalling by cleaving the <scp>LUBAC</scp> subunit <scp>HOIL</scp>‐1